FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783242767> ?p ?o ?g. }

• W2783242767 endingPage "945" @default.
• W2783242767 startingPage "936" @default.
• W2783242767 abstract "Low levels of insulinlike growth factor 1 (IGF-1) in pediatric and adolescent Crohn disease (CD) likely contribute to bone and muscle deficits.Assess changes in IGF-1 levels and associations with bone and muscle accrual following initiation of anti-tumor necrosis factor α (TNF-α) therapy in pediatric and adolescent CD.Participants (n = 75, age 5 to 21 years) with CD were enrolled in a prospective cohort study; 63 completed the 12-month visit.IGF-1 levels at baseline and 10 weeks, as well as dual-energy x-ray absorptiometry (DXA) and tibia peripheral quantitative computed tomography (pQCT) measures of bone and muscle at baseline and 12 months after initiation of anti-TNF-α therapy. Outcomes were expressed as sex-specific z scores.IGF-1 z scores increased from a median (interquartile range) of -1.0 (-1.58 to -0.17) to -0.36 (-1.04 to 0.36) over 10 weeks (P < 0.001). Lesser disease severity and systemic inflammation, as well as greater estradiol z scores (in girls), was significantly associated with greater IGF-1 z scores over time. DXA whole-body bone mineral content, leg lean mass, and total hip and femoral neck bone mineral density (BMD) z scores were low at baseline (P < 0.0001 vs reference data) and increased significantly (P < 0.001) over 12 months. Greater increases in IGF-1 z scores over 10 weeks predicted improvement in DXA bone and muscle outcomes and pQCT trabecular BMD and cortical area. Adjustment for changes in muscle mass markedly attenuated the associations between IGF-1 levels and bone outcomes.Short-term improvements in IGF-1 z scores predicted recovery of bone and muscle outcomes following initiation of anti-TNF-α therapy in pediatric CD. These data suggest that disease effects on growth hormone metabolism contribute to musculoskeletal deficits in CD." @default.
• W2783242767 created "2018-01-26" @default.
• W2783242767 creator A5003400461 @default.
• W2783242767 creator A5003413325 @default.
• W2783242767 creator A5023154420 @default.
• W2783242767 creator A5034407359 @default.
• W2783242767 creator A5037750455 @default.
• W2783242767 creator A5040726727 @default.
• W2783242767 creator A5051128371 @default.
• W2783242767 creator A5060357056 @default.
• W2783242767 creator A5060693430 @default.
• W2783242767 creator A5066322177 @default.
• W2783242767 creator A5080556901 @default.
• W2783242767 creator A5081001216 @default.
• W2783242767 date "2018-01-10" @default.
• W2783242767 modified "2023-10-06" @default.
• W2783242767 title "Increases in IGF-1 After Anti–TNF-α Therapy Are Associated With Bone and Muscle Accrual in Pediatric Crohn Disease" @default.
• W2783242767 cites W1835027475 @default.
• W2783242767 cites W1976081396 @default.
• W2783242767 cites W1990803534 @default.
• W2783242767 cites W1990835223 @default.
• W2783242767 cites W1993494426 @default.
• W2783242767 cites W1995575367 @default.
• W2783242767 cites W2001523598 @default.
• W2783242767 cites W2001850203 @default.
• W2783242767 cites W2002794415 @default.
• W2783242767 cites W2003998239 @default.
• W2783242767 cites W2012740923 @default.
• W2783242767 cites W2017365275 @default.
• W2783242767 cites W2021387012 @default.
• W2783242767 cites W2025041318 @default.
• W2783242767 cites W2026084643 @default.
• W2783242767 cites W2027672816 @default.
• W2783242767 cites W2028624096 @default.
• W2783242767 cites W2039767139 @default.
• W2783242767 cites W2047587927 @default.
• W2783242767 cites W2055883753 @default.
• W2783242767 cites W2056788640 @default.
• W2783242767 cites W2057962659 @default.
• W2783242767 cites W2060587883 @default.
• W2783242767 cites W2062814325 @default.
• W2783242767 cites W2063740389 @default.
• W2783242767 cites W2068853602 @default.
• W2783242767 cites W2069995375 @default.
• W2783242767 cites W2076543888 @default.
• W2783242767 cites W2089399826 @default.
• W2783242767 cites W2100483626 @default.
• W2783242767 cites W2113777483 @default.
• W2783242767 cites W2128683464 @default.
• W2783242767 cites W2146933101 @default.
• W2783242767 cites W2162279588 @default.
• W2783242767 cites W2162998896 @default.
• W2783242767 cites W2175935926 @default.
• W2783242767 cites W2270754374 @default.
• W2783242767 cites W2343601324 @default.
• W2783242767 cites W2475488208 @default.
• W2783242767 cites W2587052085 @default.
• W2783242767 cites W2920836380 @default.
• W2783242767 cites W4235237096 @default.
• W2783242767 doi "https://doi.org/10.1210/jc.2017-01916" @default.
• W2783242767 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6276706" @default.
• W2783242767 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29329430" @default.
• W2783242767 hasPublicationYear "2018" @default.
• W2783242767 type Work @default.
• W2783242767 sameAs 2783242767 @default.
• W2783242767 citedByCount "27" @default.
• W2783242767 countsByYear W27832427672018 @default.
• W2783242767 countsByYear W27832427672019 @default.
• W2783242767 countsByYear W27832427672020 @default.
• W2783242767 countsByYear W27832427672021 @default.
• W2783242767 countsByYear W27832427672022 @default.
• W2783242767 countsByYear W27832427672023 @default.
• W2783242767 crossrefType "journal-article" @default.
• W2783242767 hasAuthorship W2783242767A5003400461 @default.
• W2783242767 hasAuthorship W2783242767A5003413325 @default.
• W2783242767 hasAuthorship W2783242767A5023154420 @default.
• W2783242767 hasAuthorship W2783242767A5034407359 @default.
• W2783242767 hasAuthorship W2783242767A5037750455 @default.
• W2783242767 hasAuthorship W2783242767A5040726727 @default.
• W2783242767 hasAuthorship W2783242767A5051128371 @default.
• W2783242767 hasAuthorship W2783242767A5060357056 @default.
• W2783242767 hasAuthorship W2783242767A5060693430 @default.
• W2783242767 hasAuthorship W2783242767A5066322177 @default.
• W2783242767 hasAuthorship W2783242767A5080556901 @default.
• W2783242767 hasAuthorship W2783242767A5081001216 @default.
• W2783242767 hasBestOaLocation W27832427671 @default.
• W2783242767 hasConcept C119060515 @default.
• W2783242767 hasConcept C120863210 @default.
• W2783242767 hasConcept C126322002 @default.
• W2783242767 hasConcept C134018914 @default.
• W2783242767 hasConcept C147583825 @default.
• W2783242767 hasConcept C188816634 @default.
• W2783242767 hasConcept C201903717 @default.
• W2783242767 hasConcept C2775854910 @default.
• W2783242767 hasConcept C2776541429 @default.
• W2783242767 hasConcept C2776886416 @default.
• W2783242767 hasConcept C2777425516 @default.
• W2783242767 hasConcept C71924100 @default.

• next